All News

    Targeted Chemo Improves Survival in Early-Stage Lung Cancer

    June 8th 2025, 2:00pm

    Article

    Using a 14-gene test to guide chemotherapy significantly improved disease-free survival in patients with early nonsquamous lung cancer.

    Utilizing AI in Prostate Cancer Care and Management

    June 7th 2025, 6:00pm

    Article

    How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.

    KITE-363 Shows High Response in B-Cell Lymphoma With Manageable Safety

    June 7th 2025, 2:00pm

    Article

    The dual-targeting CAR T-cell therapy KITE-363 showed positive response rates and manageable side effects in relapsed or refractory B-cell lymphoma.

    Zyprexa Added to Standard Antiemetics Reduces Nausea, Vomiting in Radiation

    June 6th 2025, 9:00pm

    Article

    Adding Zyprexa to ondansetron cut nausea and vomiting safely in abdominal/pelvic radiation with low-emetogenic capecitabine.

    Sasanlimab-BCG Combo May Delay Recurrence in Bladder Cancer

    June 6th 2025, 8:00pm

    Video

    Adding subcutaneous sasanlimab to BCG improved recurrence-free survival in non–muscle-invasive bladder cancer, according to Dr. Petros Grivas.

    Personalized Vaccine Elicits Responses in Patients With Kidney Cancer

    June 6th 2025, 7:00pm

    Article

    CURE spoke with the principal investigator of a clinical trial evaluating a therapeutic vaccine for patients with advanced kidney cancer.

    The Invisibility of Blood Cancers to Others

    June 6th 2025, 5:00pm

    Article

    I describe what it is like to have an “invisible” cancer.

    MVdeltaC Earns Orphan Drug Status for Pleural Mesothelioma

    June 6th 2025, 3:00pm

    Article

    The FDA granted orphan drug designation to MVdeltaC, a measles virus-based immunotherapy, for pleural mesothelioma, supporting its future development.

    Surgery Linked to Longer Survival in Oligometastatic Lung Cancer

    June 6th 2025, 1:00pm

    Article

    Patients with oligometastatic lung cancer may live longer with surgery, but experts stress the need for multidisciplinary evaluation to guide treatment choices.

    A Unicorn Among Us

    June 5th 2025, 9:00pm

    Article

    Katherine has an exquisite instinct for understanding that there is a context to each patient’s diagnosis that is just as important to understand.